Navigation Links
Encorium Reports First Quarter 2009 Financial Results
Date:5/19/2009

's European operations in the first quarter of 2009, direct expenses also decreased as a result of reductions in staff and subcontractors utilized on active clinical studies being conducted in the U.S. and Europe.

Selling, general, and administrative expenses (SG&A) decreased by 23.2% to $2.7 million, or 38.0% of net revenue, for the three months ended March 31, 2009, compared to $3.5 million, or 46.4% of net revenue, for the three months ended March 31, 2008. The decrease in SG&A resulted primarily from staff reductions and reductions in overhead expenses in the Company's U.S. operations.

Depreciation and amortization expense decreased by 70.4% to $190,929 for the three months ended March 31, 2009 from $645,277 for the three months ended March 31, 2008 primarily as a result of certain intangible assets acquired as part of the Remedium acquisition being fully amortized.

The Company reported a significant reduction in its net loss for the first quarter of 2009 to $195,220, or $(0.01) per diluted share, from a net loss of $2.0 million, or $(0.10) per diluted share in the first quarter of 2008.

Encorium has entered into two letters of intent ("LOI") with respect to the sale of the assets used to conduct its U.S. operations and for the sale of its wholly owned European subsidiary, Encorium Oy.

Dr. David Ginsberg, Encorium Group's Chief Executive Officer, commented, "We are very pleased with the results of our cost cutting efforts, which significantly reduced our direct expenses and SG&A to better align our costs to our current book of business. We have entered into two separate LOIs to sell the assets used in the U.S. Operations and the European Operations, which we believe will maximize stockholder value and are in the best interest of our stockholders, customers and employees."

Financial Position

Encorium's balance sheet at March 3
'/>"/>

SOURCE Encorium Group, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Encorium Group Enters into Non-Binding Letters of Intent
2. Encorium Reports Fourth Quarter and Full Year 2008 Financial Results
3. Encorium Announces Receipt of Letter from Nasdaq Regarding its 2008 Form 10-K Filing
4. Encorium Appoints Shahab Fatheazam to its Board of Directors
5. BioHorizons Reports on Comparative 3-Year Dental Implant Study Showing Significant Crestal Bone and Soft Tissue Retention Using Laser-Lok(R) Microchannels
6. Escalon(R) Reports Third Quarter Fiscal 2009 Results
7. Encision Reports Fourth Quarter and Fiscal Year 2009 Results
8. BMP Sunstone Reports First Quarter 2009 Financial Results
9. Lotus Pharmaceuticals, Inc. Reports First Quarter 2009 Financial Results
10. Jiangbo Pharmaceuticals Reports Results for the Third Quarter of its Fiscal Year 2009
11. AdCare Health Systems, Inc. Turns Profitable; Reports 2009 First Quarter Earnings Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... , ... July 29, 2015 , ... Andrzej Klos, M.D., ... Klos, a board-certified pediatrician for nearly 38 years, is motivated each and every day ... commitment to his profession shine alongside his many awards and accolades, which include multiple ...
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... ... a white paper, Our Best Shot: Expanding Prevention through Vaccination in Older Adults, ... seniors and offers recommendations on how industry, government, and health care experts can ...
(Date:7/29/2015)... ... ... " Core Organizer ” was featured on NewsWatch as part of its monthly AppWatch, ... iOS, Android, and Windows. Joe Toohey, the host of AppWatch and technology expert, conducted ... organized. , Wouldn’t it be great if everyone could be a little more organized? ...
(Date:7/29/2015)... ... July 29, 2015 , ... Angelo’s FabriClean, an area rug cleaning ... damage restoration of carpets and rugs. The company will now reverse the damage caused ... , An overflowing overhead tank, rain leaking through an accidently left open window ...
(Date:7/29/2015)... ... 2015 , ... The report “Atherosclerosis - Pipeline Review, H1 ... slow, progressive disease that may start in childhood. The report strengthens R&D pipelines ... report on Atherosclerosis Pipeline with 78 market data tables and 15 figures, spread ...
Breaking Medicine News(10 mins):Health News:NJ Top Docs Presents, Dr. Andrzej Klos of Carepoint Health Pediatrics! 2Health News:NJ Top Docs Presents, Dr. Andrzej Klos of Carepoint Health Pediatrics! 3Health News:Vaccination Rates in Older Adults Fall Short of Targets 2Health News:Vaccination Rates in Older Adults Fall Short of Targets 3Health News:Get More Organized with the Core Organizer App 2Health News:Angelo’s FabriClean Now Offers Water Damage Restoration For Residential and Commercial Accounts 2Health News:Atherosclerosis Pipeline Assessment Review H1 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Atherosclerosis Pipeline Assessment Review H1 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:Atherosclerosis Pipeline Assessment Review H1 2015 Market Research Report Available at RnRMarketResearch.com 4
... providing high-quality information to professionals in the pharmaceutical ... in Therapy, to be published from 2008. With ... clients in the pharmaceutical, healthcare and biotechnology industries. ... published by Springer Healthcare Communications (SHC), will continue ...
... Advice, about Red Meat and Cancer ... K. Young, M.S., R.D., Vice President, Nutrition, National Cattlemen,s ... Beef Association, DENVER, Oct. 31 ... for consumers.,There are volumes of research about the benefits of red meat in a ...
... partly seasonal * Online advertised vacancies ... over the year gains in advertised ... vacancies, ... Oct. 31 In October there were 4,161,700,online advertised vacancies, a decrease of ...
... viruses have a strong tropism for hepatocytes; viral antigen ... pancreatitis is common in Fulminant hepatic failure but rarely ... acute viral hepatitis over a three year period were ... 7 had acute pancreatitis and 17 had stretching of ...
... Inc. (NTI(R)) (Nasdaq: NTII ), today announced ... GmbH (Merz) for sales,by Merz and its marketing ... Alzheimer,s disease for the quarter ended June 30,2007. ... payments compared to,the same quarter last year, and ...
... 31 Biopure Corporation,(Nasdaq: BPUR ) announced today ... will revert from BPURD to BPUR at the open ... that trade on the OTCBB,will revert to the following ... and BPREL reverting to BPURL. Biopure Corporation ...
Cached Medicine News:Health News:NCBA Statement on 2007 WCRF/AICR Second Expert Report on Food, Nutrition and Physical Activity and the Prevention of Cancer: 2Health News:Online Advertised Job Vacancies Dip in October, The Conference Board Reports Today 2Health News:Online Advertised Job Vacancies Dip in October, The Conference Board Reports Today 3Health News:Online Advertised Job Vacancies Dip in October, The Conference Board Reports Today 4Health News:Online Advertised Job Vacancies Dip in October, The Conference Board Reports Today 5Health News:Online Advertised Job Vacancies Dip in October, The Conference Board Reports Today 6Health News:Is it pancreatitis in acute abdominal pain in acute viral hepatitis? 2Health News:Biopure's Stock Symbol Reverts to BPUR 2
(Date:7/29/2015)... 2015   KaloBios Pharmaceuticals, Inc . (Nasdaq: ... innovative therapies to benefit patients with diseases of unmet ... that the U.S. Food and Drug Administration (FDA) has ... KB003, an anti-GM-CSF monoclonal antibody (mAb), in patients with ... now active. The acceptance of this IND ...
(Date:7/29/2015)... 29, 2015  The Perinatal Quality Foundation (PQF) ... of the advantages, limitations and clinically appropriate interpretation ... diagnostic tests for pregnant women and their healthcare ... world,s leading provider of diagnostic information services, is ... through a grant. Through a ...
(Date:7/29/2015)... CAESAREA, Israel , July 29, 2015 /PRNewswire/-- LabStyle Innovations ... was featured in a national broadcast news segment in ... Australia following regulatory and reimbursement approval ... benefits for the 1.2 million Australians living with diabetes. As ... Dario was a great solution for a 13 year old ...
Breaking Medicine Technology:KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia 2KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia 3KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia 4KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia 5Quest Diagnostics Collaborates with Perinatal Quality Foundation on National Initiative to Advance Clinically Appropriate Noninvasive Prenatal Screening 2Quest Diagnostics Collaborates with Perinatal Quality Foundation on National Initiative to Advance Clinically Appropriate Noninvasive Prenatal Screening 3Quest Diagnostics Collaborates with Perinatal Quality Foundation on National Initiative to Advance Clinically Appropriate Noninvasive Prenatal Screening 4LabStyle Innovations' Dario Diabetes Management Solution Featured on 9 News Australia 2LabStyle Innovations' Dario Diabetes Management Solution Featured on 9 News Australia 3
... U.S. Agency for International Development (USAID) continues to provide ... the midst of an expanding humanitarian crisis. An ailing ... the people of Zimbabwe in danger of other health ... supporting emergency Indoor Residual Spraying (IRS) to shore up ...
... high Dk hybrid contact lens manufacturer, announced today the ... fund the development and clinical trials for next-generation hybrid ... efforts globally. De Novo Ventures of Palo Alto, CA, ... round. Bio-Star Private Equity Fund joined Series A and ...
Cached Medicine Technology:USAID Provides Malaria Assistance to Zimbabwe 2SynergEyes, Inc. Raises $13.3 Million in 'Series C' Financing 2
AccuSign® DOA Series Opiates Test...
... SureStep™ Drug Screen Tests are available in ... MDMA (Ecstasy). Designed using Microgenics Antibody Technology, ... only point of care immunoassay targeted to ... both MDA and MDEA but no cross-reactivity ...
The SEDITAINER Erythrocyte Sedimentation Rate (ESR) System is for collection of blood specimens for the measurement of ESR within the blood collection tube, using the SEDITAINER ESR Stand....
... NMP22® Test Kit is a quantitative microplate enzyme ... are at risk for rapid recurrence or occult ... voided urine sample and is twice as sensitive ... to improve patient outcome by identifying those patients ...
Medicine Products: